Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
David M. Herrington, John W. Sanders, Thomas F. Wierzba, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

COVID-19 transmission dynamics underlying epidemic waves in Kenya
Samuel P. C. Brand, John Ojal, Rabia Aziza, et al.
Science (2021) Vol. 374, Iss. 6570, pp. 989-994
Open Access | Times Cited: 79
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Chenyang Zhang, Guosheng Yin
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1817-1821
Closed Access | Times Cited: 42
Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada
Kate Zinszer, Katia Charland, Laura Pierce, et al.
International Journal of Infectious Diseases (2023) Vol. 131, pp. 119-126
Open Access | Times Cited: 15
Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study
Sanjeeb Kumar Mishra, Subrat Kumar Pradhan, Sanghamitra Pati, et al.
Cureus (2021)
Open Access | Times Cited: 34
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
Taraz Samandari, Joshua Ongalo, Kimberly D. McCarthy, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 14
A stronger antibody response in increased disease severity of SARS-CoV-2
Marta Iglis de Oliveira, Melayne Rocha Aciole, Patrícia Areias Feitosa Neves, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA
Gregor Paul, Philipp Strnad, Oliver Wienand, et al.
Infection (2022) Vol. 51, Iss. 1, pp. 83-90
Open Access | Times Cited: 12
Volumetric Absorptive Microsampling: Its Use in Covid-19 Research and Testing
James Rudge, Stuart Kushon
Bioanalysis (2021) Vol. 13, Iss. 24, pp. 1851-1863
Open Access | Times Cited: 17
The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance
Daša Stupica, Stefan Collinet‐Adler, Nataša Kejžar, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1191-1191
Open Access | Times Cited: 10
Impact of COVID-19 Vaccination on Seroprevalence of SARS-CoV-2 among the Health Care Workers in a Tertiary Care Centre, South India
Divyaa Elangovan, Shifa Meharaj Shaik Hussain, Somasunder Virudhunagar Muthuprakash, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1967-1967
Open Access | Times Cited: 8
Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection
Pragya D. Yadav, Rima R. Sahay, Sukeshani Salwe, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-19
Open Access | Times Cited: 4
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
Enrico Richter, Dominik Liebl, Bianca Schulte, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership
John Williamson, Thomas F. Wierzba, Michele Santacatterina, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0260574-e0260574
Open Access | Times Cited: 5
Effects of SARS-CoV-2 gestational exposure and risk factors on neurodevelopment until 12 months: A prospective cohort study in Brazil
Gabriela Soutto Mayor Assumpção Pinheiro, Stela Maris Aguiar Lemos, Isadora de Araújo Martins, et al.
Early Human Development (2023) Vol. 188, pp. 105918-105918
Closed Access | Times Cited: 2
Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa
Nicole Kogan, Shae Gantt, David L. Swerdlow, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. 424-432
Open Access | Times Cited: 4
Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort
Noa Kopplin, Angie Garcia, Annika Reczek, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291259-e0291259
Open Access | Times Cited: 2
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up
Annachiara Coppola, Carlo Buonerba, Davide Cardinale, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 5
Association of social vulnerability index and masking adherence among children enrolled in COVID-19 community research partnership study
Keerti L. Dantuluri, Asare Buahin, Diane Uschner, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022
Carolyn Gigot, Nora Pisanic, Kristoffer Spicer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
T‐cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes
Camillo Palmieri, Gianluca Santamaria, Costanza Maria Cristiani, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 4
Closed Access
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020–2022
Joule Madinga, Placide Mbala‐Kingebeni, Antoine Nkuba-Ndaye, et al.
Journal of Health Population and Nutrition (2024) Vol. 43, Iss. 1
Open Access
Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children
Amina Ahmed, Whitney Rossman, Lauren C Lu, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 3
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
John Kimotho, Yiakon Sein, Shahin Sayed, et al.
Wellcome Open Research (2024) Vol. 8, pp. 350-350
Open Access
Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia
Aimée Altermatt, Katherine Heath, Freya Saich, et al.
Australian and New Zealand Journal of Public Health (2023) Vol. 47, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top